Atorvastatin in Myeloma

Bayside Health

Status and phase: Unknown; Phase 1

Conditions: Myeloma

Treatments: Drug: atorvastatin

Study type: Interventional

Funder types: Other

Identifiers

NCT00164086

7/04

Details and patient eligibility

About

The purpose of this trial is to study the effects of a medication already widely used to treat cardiovascular disease and diabetes, in reducing the progression of myeloma.

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Myeloma in remission

Exclusion criteria

• Adverse events (AEs) to statin, already on a statin, or contraindication to statin

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)